Patent 7071336 was granted and assigned to Acura Pharmaceuticals on July, 2006 by the United States Patent and Trademark Office.
Oxycodone is manufactured in high yields and with a high purity using a composition including a thebaine component into 14-hydroxycodeinone and then reduction of 14-hydroxycodeinone to oxycodone.